Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Carrier

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
European Heart Journal|April 30, 2005
Diagnostic accuracy of a 2D left ventricle hypertrophy score for familial hypertrophic cardiomyopathyJean F Forissier, Philippe Charron, Sophie Tezenas du Montcel, et al.
Cardiovascular Research|October 24, 2009
Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanismsGiulia Mearini, Christina Gedicke, Saskia Schlossarek, et al.
Journal of Molecular and Cellular Cardiology Plus|January 13, 2025
Sacubitril/valsartan reduces proteasome activation and cardiomyocyte area in an experimental mouse model of hypertrophyMoritz Meyer-Jens, Kristin Wenzel, Karina Grube, et al.
Plos One|June 6, 2012
Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive miceFeriel Azibani, Yvan Devaux, Guillaume Coutance, et al.
The American Journal of Pathology|April 26, 2011
Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathyCatherine Meyer-Schwesinger, Tobias N Meyer, Henning Sievert, et al.
Molecular Biosystems|December 2, 2014
Changes in the cardiac metabolome caused by perhexiline treatment in a mouse model of hypertrophic cardiomyopathyKatja Gehmlich, Michael S Dodd, J William Allwood, et al.
Molecular Therapy. Nucleic Acids|June 19, 2017
Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived CardiomyocytesMaksymilian Prondzynski, Elisabeth Krämer, Sandra D Laufer, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 29, 2017
Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial TrabeculaeIngra Mannhardt, Alexandra Eder, Berengere Dumotier, et al.
Biochemical and Biophysical Research Communications|October 16, 2010
The new HNO donor, 1-nitrosocyclohexyl acetate, increases contractile force in normal and β-adrenergically desensitized ventricular myocytesAli El-Armouche, Azadeh Wahab, Katrin Wittköpper, et al.
Journal of Molecular Biology|October 22, 2008
Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathyUdin Bahrudin, Hiroko Morisaki, Takayuki Morisaki, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
European Heart Journal|April 30, 2005
Diagnostic accuracy of a 2D left ventricle hypertrophy score for familial hypertrophic cardiomyopathyJean F Forissier, Philippe Charron, Sophie Tezenas du Montcel, et al.
Cardiovascular Research|October 24, 2009
Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanismsGiulia Mearini, Christina Gedicke, Saskia Schlossarek, et al.
Journal of Molecular and Cellular Cardiology Plus|January 13, 2025
Sacubitril/valsartan reduces proteasome activation and cardiomyocyte area in an experimental mouse model of hypertrophyMoritz Meyer-Jens, Kristin Wenzel, Karina Grube, et al.
Plos One|June 6, 2012
Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive miceFeriel Azibani, Yvan Devaux, Guillaume Coutance, et al.
The American Journal of Pathology|April 26, 2011
Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathyCatherine Meyer-Schwesinger, Tobias N Meyer, Henning Sievert, et al.
Molecular Biosystems|December 2, 2014
Changes in the cardiac metabolome caused by perhexiline treatment in a mouse model of hypertrophic cardiomyopathyKatja Gehmlich, Michael S Dodd, J William Allwood, et al.
Molecular Therapy. Nucleic Acids|June 19, 2017
Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived CardiomyocytesMaksymilian Prondzynski, Elisabeth Krämer, Sandra D Laufer, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 29, 2017
Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial TrabeculaeIngra Mannhardt, Alexandra Eder, Berengere Dumotier, et al.
Biochemical and Biophysical Research Communications|October 16, 2010
The new HNO donor, 1-nitrosocyclohexyl acetate, increases contractile force in normal and β-adrenergically desensitized ventricular myocytesAli El-Armouche, Azadeh Wahab, Katrin Wittköpper, et al.
Journal of Molecular Biology|October 22, 2008
Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathyUdin Bahrudin, Hiroko Morisaki, Takayuki Morisaki, et al.
Pageof 15